June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Functional analysis of tissue engineered corneal endothelium from human skin derived precursors.
Author Affiliations & Notes
  • Emi Inagaki
    Ophthalmology, Keio University, Tokyo, Japan
  • Shin Hatou
    Ophthalmology, Keio University, Tokyo, Japan
  • Kazunari Higa
    Ophthalmology, Keio University, Tokyo, Japan
  • Hideyuki Miyashita
    Ophthalmology, Keio University, Tokyo, Japan
  • Satoru Yoshida
    Ophthalmology, Keio University, Tokyo, Japan
  • Kazuo Tsubota
    Ophthalmology, Keio University, Tokyo, Japan
  • Shigeto Shimmura
    Ophthalmology, Keio University, Tokyo, Japan
  • Footnotes
    Commercial Relationships Emi Inagaki, None; Shin Hatou, None; Kazunari Higa, None; Hideyuki Miyashita, None; Satoru Yoshida, None; Kazuo Tsubota, None; Shigeto Shimmura, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3450. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Emi Inagaki, Shin Hatou, Kazunari Higa, Hideyuki Miyashita, Satoru Yoshida, Kazuo Tsubota, Shigeto Shimmura; Functional analysis of tissue engineered corneal endothelium from human skin derived precursors.. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3450.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Corneal endothelial dysfunction remains a major indication for corneal transplantation. However, corneal transplantation has problems such as shortage of donors and graft rejection. Skin-derived precursors (SKPs) are post-natal stem cells of neural crest origin, similar to the corneal endothelium. In this study, we show the functional analysis of tissue engineered corneal endothelium derived from human SKPs.<br />

Methods: Human SKPs (hSKPs) were isolated from the eyelid skin taken from patients undergoing eyelid surgery and then cultured in SKPs proliferation medium. hSKPs-TECE (tissue engineered corneal endothelium) was induced in a medium containing retinoic acid and glycogen synthase kinase (GSK) 3b inhibitor (activator of Wnt/b-catenin signaling) by the method we previously reported using murine SKPs. To assess the function of TECE in vitro, we used the Ussing[S1] chamber which is an apparatus for measuring trans-endothelial resistance (TER) and pump function of monolayer cells. Human corneal endothelial cell line (B4G12 cell) was used as control.<br /> <br /> <br />

Results: The TER of hSKPs-TECE was 17.96±4.16 (Ω/cm2), control B4G12 was 8.86±0.67 (Ω/cm2). Na,K-ATPase pump activity of SKPs-TECE was calculated by the difference of short-circuit current before and after Ouabine addition. Na,K-ATPase pump activity of SKPs-TECE was 2.64±0.32 (mV/cm2), control B4G12 was 0.79±0.03 (mV/cm2). hSKPs-TECE has significantly higher pump function (3.3-fold) compared to control B4G12 cells.<br />

Conclusions: We successfully induced functionally differentiated tissue engineered corneal endothelium from human postnatal stem cells derived from skin. This may lead to a novel autologous stem cell therapy for corneal endothelial function.<br />

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×